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Rules of engagement: the discovery of MHC restriction
 
Before there was a defined T cell receptor, Peter Doherty and Rolf Zinkernagel 
deciphered the rules that governed its recognition of infected target cells.
 
Immunological compatibility in the
1970s was defined by transplantation an-
tigens—now known as the molecules
encoded by the major histocompatibility
complex (MHC). These proteins dic-
tated the compatibility of transplanted tu-
mors among different strains of mice.
They also set the stage for Rolf Zinker-
nagel and Peter Doherty to discover the
phenomenon of MHC restriction of an-
tiviral responses. For this discovery they
were awarded the 1996 Nobel Prize in
Physiology or Medicine.
 
Combined talents
 
In 1973, Zinkernagel and Doherty
combined forces on studies of lympho-
cytic choriomeningitis virus (LCMV),
which in mice causes a fatal neurologic
disease with T cell invasion of the cen-
tral nervous system (CNS). By com-
bining their talents—Doherty doing
spinal taps on mice, and Zinkernagel
the 
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Cr-release cytotoxicity assays—
they demonstrated that the T cells re-
covered from the cerebrospinal fluid of
infected mice were antigen-specific cy-
totoxic T cells (CTLs) that could de-
stroy LCMV-infected L cells (mouse fi-
broblast cells) (1). This supplied the test
system used in the pivotal MHC re-
striction study.
 
Fortuitous choices
 
Michael Oldstone and colleagues had
suggested that different strains of mice
showed subtle differences in suscep-
tibility to LCMV infection (2). In-
trigued, Zinkernagel and Doherty set
out to determine whether these differ-
ences were a function of cytolytic T
cell activity in the CNS. They col-
lected the available strains of mice—a
grand total of four—and tested their
CNS-invading T cells for the ability to
destroy infected L cells. All the mice
eventually died, but surprisingly only
some of the strains developed cytolytic
T cell responses in vitro (3).
Genetic background and fortuity
explained this finding. The available
reagents had been a mouse strain
(CBA) and a cell line (L cells) that both
expressed MHC molecules of the H-2
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haplotype. It was this combination that
showed an effective cytolytic T cell re-
sponse. Thus, the ability of T cells to
recognize target cells was a function of
both antigen and MHC haplotype.
They proved this formally by replacing
the L cells with macrophages from each
of the mouse strains. Immune T cells
could only recognize infected target
cells that shared the same H-2 haplo-
type (3). Although this made sense
based on prior reports of MHC re-
quirements for T–B cell collaborations,
the results were unexpected. “Nobody
had thought of such a limitation on the
interaction between T cells and virus-
infected cells,” notes Zinkernagel.
The duo fine-tuned the rules gov-
erning MHC restriction using congenic
and recombinant mouse strains to pin-
point the restriction element to the K
and D regions (class I) of the MHC
complex and to rule out involvement of
the I region (class II) (4, 5). These studies
were published in a series of articles in
the 
 
Journal of Experimental Medicine.
 
A contentious model
 
There were two possible explanations
for the influence of the MHC on T cell
recognition of infected cells. The first
was that T cells express two receptors,
one for identification of self cells that
was dictated by like-like MHC interac-
tions, and another (T cell receptor) for
recognition of antigen. The second
possibility—the one they favored—was
that the T cell receptor recognizes a vi-
rus-induced modification of the MHC
product—the “altered-self” hypothesis.
The altered-self model was not
popular among many of Zinkernagel
and Doherty’s contemporaries. But
their later
 
experiments showed that T
cells from the F1 (AxB) offspring of two
MHC-disparate mice recognized only
the altered self of MHC-A target cells
or MHC-B target cells, but not both
(6). This result cast doubt on the dual
receptor model in which F1 T cells,
having both A and B MHC molecules,
should have recognized both targets.
“The whole thing broke open ten
years later when the molecular biolo-
gists got involved,” recalls Doherty. In-
deed, it wasn’t until the class I MHC
processing pathway and the structure of
the T cell receptor were defined that
the duo and the altered-self hypothesis
were vindicated (7, 8).
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Doherty and Zinkernagel with their Nobel Prizes, 
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